{"abstract": "Ablation Frontiers, which develops treatments for cardiac arrhythmia, said it closed a $21.8 million round of venture funding led by Novartis Venture Fund. The round also included new investors Affinity Capital Management, Hexagon Investments and Trellis Health Ventures. ", "web_url": "https://dealbook.nytimes.com/2007/07/19/ablation-frontiers-raises-218-million/", "snippet": "", "lead_paragraph": "Ablation Frontiers, which develops treatments for cardiac arrhythmia, said it closed a $21.8 million round of venture funding led by Novartis Venture Fund. The round also included new investors Affinity Capital Management, Hexagon Investments and Trellis Health Ventures. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Ablation Frontiers Raises $21.8 Million", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2007-07-19T11:00:45+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By", "person": [], "organization": null}, "type_of_material": "News", "_id": "nyt://article/1ca292e4-293f-5edb-8631-36ef354ea883", "word_count": 84, "uri": "nyt://article/1ca292e4-293f-5edb-8631-36ef354ea883"}